KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Prepaid Assets: 2009-2024

Historic Prepaid Assets for Acadia Pharmaceuticals (ACAD) over the last 16 years, with Dec 2024 value amounting to $55.7 million.

  • Acadia Pharmaceuticals' Prepaid Assets rose 18.08% to $60.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.9 million, marking a year-over-year increase of 18.08%. This contributed to the annual value of $55.7 million for FY2024, which is 42.44% up from last year.
  • Acadia Pharmaceuticals' Prepaid Assets amounted to $55.7 million in FY2024, which was up 42.44% from $39.1 million recorded in FY2023.
  • Acadia Pharmaceuticals' Prepaid Assets' 5-year high stood at $55.7 million during FY2024, with a 5-year trough of $21.4 million in FY2022.
  • Moreover, its 3-year median value for Prepaid Assets was $39.1 million (2023), whereas its average is $38.7 million.
  • In the last 5 years, Acadia Pharmaceuticals' Prepaid Assets declined by 10.44% in 2022 and then skyrocketed by 82.69% in 2023.
  • Over the past 5 years, Acadia Pharmaceuticals' Prepaid Assets (Yearly) stood at $25.7 million in 2020, then declined by 7.01% to $23.9 million in 2021, then dropped by 10.44% to $21.4 million in 2022, then soared by 82.69% to $39.1 million in 2023, then surged by 42.44% to $55.7 million in 2024.